Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

ANTIPLATELET THERAPY

Aspirin dosing for secondary prevention in ASCVD

This is a preview of subscription content

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.

from$8.99

All prices are NET prices.

References

Original article

  1. Jones, W. S. et al. Comparative effectiveness of aspirin dosing in cardiovascular disease. N. Engl. J. Med. https://doi.org/10.1056/NEJMoa2102137 (2021)

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Affiliations

Authors

Corresponding author

Correspondence to Irene Fernández-Ruiz.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Fernández-Ruiz, I. Aspirin dosing for secondary prevention in ASCVD. Nat Rev Cardiol 18, 544 (2021). https://doi.org/10.1038/s41569-021-00576-7

Download citation

Search

Quick links